[] Recently, a new emerging interest in GLP-1 as therapeutic options for DM from their glucose-dependent mechanism of action, which enhances insulin secretion, reduces glucagon release, delays gastric emptying, and promotes satiety, ultimately helping control blood glucose without severe hypoglycemia
Triglyceride reductions are 5-10% greater, and the overall lipid profile improvement is more comprehensive
This provides a physical buffer for the stomach while ensuring that the nutrients and the medication are processed smoothly
Glutathione and Vitamin C both have antioxidant properties that help to protect the skin from this damage, keeping it healthy and radiant
It can be described as an imbalance in ROS generation and antioxidant defence leading to accumulation of ROS
10.1038/srep10720 8 CoppJ